Tirzepatide reconstitution calculator
- Concentration
- 5 mg/mL
- Doses per vial
- 4
- Weeks (1 dose/wk)
- 4
50 units (0.5 mL) on a 1 mL U-100 syringe: 2.5 mg from a 10 mg vial + 2 mL water (Tirzepatide).
Dosing table for a 10 mg vial
Syringe units (U-100) for each dose, by how much bacteriostatic water you add.
| Dose | 1 mL water | 2 mL water | 2.5 mL water | 3 mL water |
|---|---|---|---|---|
| 1 mg | 10 | 20 | 25 | 30 |
| 2.5 mg | 25 | 50 | 62.5 | 75 |
| 5 mg | 50 | 100 | 125 | 150 |
| 7.5 mg | 75 | 150 | 187.5 | 225 |
| 10 mg | 100 | 200 | 250 | 300 |
How the math works
Concentration is the vial's milligrams divided by the water you add. Volume to draw is your dose divided by that concentration. On a U-100 syringe, 1 mL is 100 units, so units = mL × 100.
2.5 mg ÷ 5 mg/mL = 0.5 mL
0.5 mL × 100 = 50 units
How many units is 2.5 mg of tirzepatide?
It depends on the vial. At 5 mg/mL (10 mg in 2 mL) it is 50 units; at 3.33 mg/mL (10 mg in 3 mL) it is 75 units; at 10 mg/mL (10 mg in 1 mL) it is 25 units.
Calculated from dose mg 2.5; vial mg 10; water m L 1, 2, 3. Formula: 2.5/10x100 = 25; 2.5/5x100 = 50; 2.5/3.333x100 = 75 units
How much bacteriostatic water for a 10 mg Tirzepatide vial?
The water only sets the concentration; the amount of Tirzepatide in the vial stays the same. 2 mL makes 5 mg/mL, so 2.5 mg is 50 units. 2.5 mL makes 4 mg/mL, so the same 2.5 mg is 62.5 units. More water makes small doses easier to measure but needs more volume per injection.
How many 2.5 mg doses are in a 10 mg vial?
10 ÷ 2.5 = 4, so 4 full doses of 2.5 mg. Any liquid lost in the needle and vial is not counted.
Is a tirzepatide calculator accurate for Zepbound vials?
The Zepbound label prints the concentration for each multi-dose vial strength, from 4.17 to 25 mg/mL.[3]
What concentration does a 30 mg tirzepatide powder vial give?
Zepbound's labelled 30 mg/2.4 mL vial is already a solution; for a powder vial, 30 mg mixed with 2 mL is 15 mg/mL and with 3 mL is 10 mg/mL. At 15 mg/mL the amounts 2.5, 5, 7.5, 10, 12.5 and 15 mg read 16.7, 33.3, 50, 66.7, 83.3 and 100 units; at 10 mg/mL they read 25, 50, 75 and 100 units, while 125 and 150 units are more than one 1 mL syringe holds.
Calculated from vial mg 30; water m L 2, 3; doses mg 2.5, 5, 7.5, 10, 12.5, 15. Formula: mg/mL = 30 / water_mL; units = dose / (mg/mL) x 100
How many mg is 50 units of tirzepatide?
50 units is 0.5 mL, which holds 2.5 mg at 5 mg/mL, 5 mg at 10 mg/mL and 7.5 mg at 15 mg/mL.
Calculated from units 50; mg per m L 5, 10, 15. Formula: 50 units = 0.5 mL; mg = 0.5 x mg_per_mL
How many injections are in a tirzepatide vial?
The label says each multi-dose vial holds 2.4 mL of solution providing 4 doses; the chart above counts the doses a powder vial would give.[3]
Preset doses are round numbers for the arithmetic, not dosing guidance. Vial sizes are the ones most often mentioned for Tirzepatide in community discussions.
What the Zepbound label says about vial strengths
The Zepbound label lists single-dose vials and multi-dose vials, and the multi-dose vials hold 4 doses.[3]
The smallest labelled multi-dose vial is 10 mg in 2.4 mL, which the label gives as 4.17 mg/mL, with each dose being 2.5 mg in 0.6 mL.[3]
At the labelled 4.17 mg/mL a 2.5 mg dose is 0.6 mL, which is 60 units on a U-100 syringe. A 10 mg vial mixed with 2 mL of water is 5 mg/mL, so the same 2.5 mg is 0.5 mL or 50 units.
Calculated from dose mg 2.5; label mg per m L 4.17; research vial mg 10; water m L 2. Formula: 2.5 / 4.17 = 0.60 mL = 60 units; 10 / 2 = 5 mg/mL; 2.5 / 5 = 0.5 mL = 50 units
The single-dose pen and vial strengths run from 2.5 mg to 15 mg, each in 0.5 mL.[3]
Vial sizes seen in the price dataset
The dataset logs 9 tirzepatide vial sizes, from 5 mg (17 listings, median $70) to 100 mg (3 listings, median $399.99). Only sizes with at least 3 distinct sellers are published, so a 120 mg size that the calculator accepts is missing from it.
Calculated from source our price listings dataset; sizes mg 5, 10, 15, 20, 30, 40, 50, 60, 100; min vendors 3. Formula: count of published sizes = 9; first and last rows read as listed
Dividing the medians gives about $14.00 per mg at 5 mg and about $4.00 per mg at 100 mg, so the per-mg price falls steeply with vial size.
Calculated from 5mg median 70, mg 5; 100mg median 399.99, mg 100. Formula: 70 / 5 = 14.00; 399.99 / 100 = 4.00 per mg
Trial doses on the syringe
The 52-week trial in people with obesity assigned 5 mg, 10 mg or 15 mg once weekly against placebo.[4]
In the trial of tirzepatide added to insulin, treatment began at 2.5 mg a week and rose by 2.5 mg every 4 weeks until the assigned dose.[5]
From a 10 mg vial in 2 mL (5 mg/mL), 5 mg measures 100 units, which fills a 1 mL syringe, and 7.5 mg measures 150 units, which does not fit in 1. A 30 mg vial in 2 mL (15 mg/mL) brings 15 mg down to 100 units.
Calculated from vial mg 10, 30; water m L 2; doses mg 5, 7.5, 15. Formula: 5/(10/2)x100 = 100; 7.5/(10/2)x100 = 150; 15/(30/2)x100 = 100 units
A 10 mg vial holds 4 doses of 2.5 mg, so a 4-week step at 2.5 mg a week uses exactly 1 vial with nothing left over, and a 4-week step at 5 mg needs 2 vials.
Calculated from vial mg 10; step mg 2.5, 5. Formula: 10 / 2.5 = 4 doses; 10 / 5 = 2 doses
Tirzepatide reconstitution chart by vial size
Tirzepatide 5 mg vial: 5 mg/mL in 1 mL (50 units for 2.5 mg); 2.5 mg/mL in 2 mL (100 units for 2.5 mg); 1.67 mg/mL in 3 mL (150 units for 2.5 mg, more than one 1 mL syringe holds).
Calculated from vial mg 5; water m L 1, 2, 3; dose mg 2.5; units per m L 100. Formula: mg/mL = 5 / water_mL; units = dose_mg / (mg/mL) x 100
Tirzepatide 10 mg vial: 10 mg/mL in 1 mL (25 units for 2.5 mg); 5 mg/mL in 2 mL (50 units for 2.5 mg); 3.33 mg/mL in 3 mL (75 units for 2.5 mg).
Calculated from vial mg 10; water m L 1, 2, 3; dose mg 2.5; units per m L 100. Formula: mg/mL = 10 / water_mL; units = dose_mg / (mg/mL) x 100
Tirzepatide 15 mg vial: 15 mg/mL in 1 mL (16.7 units for 2.5 mg); 7.5 mg/mL in 2 mL (33.3 units for 2.5 mg); 5 mg/mL in 3 mL (50 units for 2.5 mg).
Calculated from vial mg 15; water m L 1, 2, 3; dose mg 2.5; units per m L 100. Formula: mg/mL = 15 / water_mL; units = dose_mg / (mg/mL) x 100
Tirzepatide 20 mg vial: 20 mg/mL in 1 mL (12.5 units for 2.5 mg); 10 mg/mL in 2 mL (25 units for 2.5 mg); 6.67 mg/mL in 3 mL (37.5 units for 2.5 mg).
Calculated from vial mg 20; water m L 1, 2, 3; dose mg 2.5; units per m L 100. Formula: mg/mL = 20 / water_mL; units = dose_mg / (mg/mL) x 100
Tirzepatide 30 mg vial: 30 mg/mL in 1 mL (8.3 units for 2.5 mg); 15 mg/mL in 2 mL (16.7 units for 2.5 mg); 10 mg/mL in 3 mL (25 units for 2.5 mg).
Calculated from vial mg 30; water m L 1, 2, 3; dose mg 2.5; units per m L 100. Formula: mg/mL = 30 / water_mL; units = dose_mg / (mg/mL) x 100
Tirzepatide 60 mg vial: 60 mg/mL in 1 mL (4.2 units for 2.5 mg); 30 mg/mL in 2 mL (8.3 units for 2.5 mg); 20 mg/mL in 3 mL (12.5 units for 2.5 mg).
Calculated from vial mg 60; water m L 1, 2, 3; dose mg 2.5; units per m L 100. Formula: mg/mL = 60 / water_mL; units = dose_mg / (mg/mL) x 100
Every labelled Zepbound multi-dose vial, 10 to 60 mg in 2.4 mL, is a ready-made solution and is not mixed; this chart applies only to unlabelled powder vials.[3]
A 2.5 mg amount uses 1 of 2 doses from a 5 mg vial, 1 of 4 from 10 mg, 1 of 6 from 15 mg, 1 of 8 from 20 mg, 1 of 12 from 30 mg and 1 of 24 from 60 mg.
Calculated from vial mg 5, 10, 15, 20, 30, 60; dose mg 2.5. Formula: doses per vial = vial_mg / dose_mg
Sources
- 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
- 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
- 3ZEPBOUND prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
- 4Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis.The New England journal of medicine · 2024PMID 38856224Accessed 2 Oct 2026
- 5Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.JAMA · 2022PMID 35133415Accessed 2 Oct 2026
Found an error? Report a correction.